Scientist advisory team
Scientist advisory team
Zhou Qilin
Zhou Qilin
● Professor, Nankai University
● Expert in chiral catalysis
Focus on asymmetric catalysis, including the design and synthesis of novel chiral ligands and chiral catalysts, the development of new asymmetric catalytic reactions, and chiral drug synthesis
● The project "Discovery of Highly efficient chiral spiral catalyst" won the first prize of the National Natural Science Award
Ma Dawei
Ma Dawei
● Researcher, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
● Mainly studies the total synthesis of complex natural products with important physiological activities, organic synthesis methodology, etc
俞飚
俞飚
● Director of the State Key Laboratory of Biological Organic Chemistry
● Expert in sugar chemistry
● The research direction is complex oligosaccharides, glycoconjugates and other natural products with important physiological activities
● Whistler Prize in Sugar Chemistry 2022 (the first Chinese scholar to win the prize)
Wang Guangji
Wang Guangji
● Expert in pharmacokinetics
● Mainly engaged in pharmacology, pharmacokinetics and toxicology research
Hu Jinbo
Hu Jinbo
● Expert in fluorine chemistry
● Focus on the research of new reagents and new reactions in fluorine chemistry
李昂
李昂
● Deputy Director of the State Key Laboratory of Biological Organic Chemistry
● Experts in the field of full synthesis
● Focus on chemical synthesis of active natural products
Tang Wenjun
Tang Wenjun
● Asymmetric catalytic reaction expert
● Focus on asymmetric catalysis and drug process research
Andreas Flueckiger
Andreas Flueckiger
● Former Global Head of Occupational Health and Toxicology at Roche Pharmaceuticals
● Extensive expertise in occupational health assessment and EHS audit
Core research team
Core research team
Che Daqing
Che Daqing
● Postdoctoral Fellow, University of Calgary, Canada
● High-level talents in Zhejiang Province
● Published more than 20 SCI articles in international journals
● Focus on small molecule drug development and green chemical process development and application, with 30 years of organic synthesis and drug synthesis experience。He is responsible for the successful development of more than 30 API green synthesis process routes and more than 2,000 small molecule compounds, and has undertaken a number of national and provincial major scientific research projects
Li Yuanqiang
Li Yuanqiang
● Postdoctoral Fellow at Columbia University
● Zhejiang Province high-level talents, "Zhejiang Province leading innovation team" main leader
● Professor level senior engineer
● Has more than 20 years of rich experience in the research and development and production of chemical apis, especially in the field of green synthesis technology (such as chiral catalysis, fluorine chemistry, continuous reaction and enzyme catalysis) technology development and industrial application has made remarkable achievements
Yin Lifang
Yin Lifang
● Postdoctoral Fellow, Peking University
● Professor and doctoral supervisor of China Pharmaceutical University
● External evaluation experts of the Drug Evaluation Center of the State Drug Administration
● Published more than 40 papers in SCI journals
● Won the first prize of Jiangsu Science and Technology Progress Award
● Engaged in pharmaceutical preparations and their quality research, pharmacokinetic research for nearly 30 years, long-term commitment to new dosage forms and new technology related research, to solve the problem of preparation industrialization and its standard determination
陈功
陈功
● Shanghai Youth Science and technology star, Taizhou City "500 Elite Plan" innovative talent
● Published 10 SCI papers and applied for 7 patents
● More than 20 years of experience in drug development and production management, and participated in the process safety assessment of more than 500 production scale-up projects
Strict census
Strict census
● 151 talents in Zhejiang Province
● Mainly studies the total synthesis of complex natural products with important physiological activities, organic synthesis methodology, etc
David A. Perrey
David A. Perrey
● Postdoctoral Fellow, Georgia Institute of Technology
● As head of Ruibo's US synthesis team, responsible for several projects including preclinical discovery, process development and low-volume production
徐峰
徐峰
● Innovative talents of Taizhou "500 Elite Plan"
● Published 5 SCI papers in international journals
● Have rich experience in customizing customer peptides, and presided over and participated in more than 10 FDA and CFDA registration projects, including peptide apis, freeze-dried powder injections, etc
Matthew G. Lauer
Matthew G. Lauer
● Postdoctoral Fellow, University of Alabama
● Focus on the synthesis route development, synthesis, separation and other research of organic and organometallic compounds, with rich experience in the development and optimization of new chemical reactions
Li Yonggang
Li Yonggang
● MBA from BI Business School, Fudan University, Norway
● Published 6 SCI articles in international journals
● Focus on API process development, with 20 years of experience in organic synthesis and process development, has completed more than 60 API process development projects and undertaken a number of city-level scientific research projects
于帅
于帅
● Postdoctoral Fellow, City University of New York, USA
● In Organic Letters, Published articles as first author in international journals such as The Journal of Organic Chemistry and ACS Medicinal Chemistry Letters
● More than 10 years of working experience in the field of total synthesis of natural products, small molecule drug development and API process development。Responsible for the successful development of more than 10 API synthesis process routes and hundreds of small molecule compounds